The ACME Laboratories Ltd. (DSE:ACMELAB)

The ACME Laboratories Revenue

The ACME Laboratories had revenue of 10.44B BDT in the quarter ending March 31, 2026, with 12.84% growth. This brings the company's total for the last twelve months to 40.05B, up 15.25% year-over-year. In the fiscal year ending June 30, 2025, The ACME Laboratories had annual revenue of 35.94B with 12.54% growth. That makes The ACME Laboratories the 13,986th largest company in the world by revenue and 17th in Bangladesh.

• Revenue (ttm): 40.05B
• Revenue Growth: +15.25%
• P/S Ratio: 0.41
• Revenue / Employee: 4.44M
• Employees: 9,025
• Market Cap: 16.38B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bangladesh 38.90B 94.1%
• Export 2.44B 5.9%
• Others 965.72K 0.0%

Fiscal year ended Jun 30, 2025 See the full The ACME Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	35.94B	4.01B	12.54%
Jun 30, 2024	31.93B	4.98B	18.49%
Jun 30, 2023	26.95B	3.09B	12.95%
Jun 30, 2022	23.86B	3.09B	14.87%
Jun 30, 2021	20.77B	1.77B	9.30%

Data Source: S&P Global Market Intelligence Last updated: Jun 1, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error